|
市場調查報告書
中國的C型肝炎市場:還沒到達高峰的傳染病
Epidemiology: Hepatitis C in China - Epidemic yet to reach its peak
| 出版商 |
Datamonitor |
| 出版日期 |
2011年11月 |
商品編碼 |
229438 |
| 內容資訊 |
英文 Pages: 26 |
| 價格 |
|
|
中國的C型肝炎市場:還沒到達高峰的傳染病 是由出版商Datamonitor在2011年11月所出版的。
這份英文市場調查報告書包含Pages: 26 價格從美金7600起跳。
1999年的全球HCV感染患者約1億8000萬人，在這之中有1億3000萬人是慢性感染疾病患者，有罹患慢性肝疾病，肝硬化，肝癌的發病的風險。中國有4000萬人以上感染HCV，顯示抗HCV藥有龐大的單一市場潛力。
本報告提供中國的HCV感染的患病人數預估與預測，HCV的遺傳基因型分佈，關於HCV流行病學的潛在的危險因素等詳細內容調查·分析，為您概述為以下內容。
第1章 執行摘要
第2章 概要
第3章 疾病定義與診斷標準
第4章 全球的變化和歷史的趨勢
- 整體患病率
- HCV的歷史的診斷率的趨勢
- HCV的遺傳基因型分佈
第5章 危險因素
- 注射藥的使用
- 輸血危險的醫療行為
- 臨產期感染
- 性行為感染
第6章 合併症
第7章 免疫學的預測
第8章 免疫學的結果
第9章 考察
- 摘要:患病人數的持續性增加
- 持續性的醫療的暴露和注射藥使用者的增加促進傳染病
- 本分析的優點與限制
第10章 參考文獻
第11章 附錄
Description
Introduction
In 1999, an estimated 180 million people worldwide were infected with HCV, of whom 130 million were chronically infected and at risk of developing chronic liver disease, cirrhosis, and hepatocellular carcinoma. In China, more than 40 million people are estimated to be infected with HCV, thereby presenting a huge single market potential for anti-HCV drugs.
Features and benefits
- Gain insights into the estimates and forecast of prevalent HCV cases in China.
- Understand the genotype distribution of HCV in China.
- Gain insights into the possible underlying risk factors driving the epidemiology of HCV in China.
Highlights
- In 2010, there were 43.4 million men, women, and children infected with HCV in China. This is expected to increase to approximately 45.2 million cases by 2020.
- The number of prevalent HCV cases will continue to rise in China due to continued healthcare exposures and as the population of injection drug users, in which HCV is the most prevalent, continues to grow. The number of HCV cases in China will increase by approximately 4.3% from 2010 to 2020.
Your key questions answered
- What is the current HCV patient population in China?
- How will the HCV patient population change over the next decade in China?
- How do changes in the risk factors affect the trends in prevalent HCV cases in China?
TOC
Executive Summary
- Disease background
- Epidemiologic forecast
OVERVIEW
DISEASE DEFINITION AND DIAGNOSIS CRITERIA
- Hepatitis C virus is a communicable disease that can cause chronic infection
GLOBAL VARIATION AND HISTORICAL TRENDS
- Overall prevalence
- Huge regional variations reflecting healthcare system's capabilities
- Historical diagnosis rate trend of HCV
- HCV genotype distribution
RISK FACTORS
- Injection drug use
- Blood transfusion and unsafe medical practice
- Perinatal transmission
- Sexual transmission
CO-MORBIDITIES
- Human immunodeficiency virus (HIV)
- Hepatitis B virus
EPIDEMIOLOGIC FORECASTING
- Sources of epidemiologic data
- Population denominators
- Description of methods
EPIDEMIOLOGIC RESULTS
- Current prevalent cases and future trends
DISCUSSION
- Summary: continued increase in prevalent cases
- Persistence of healthcare exposures and growth in number of injection drug users drives epidemic
- Strengths and limitations of this analysis
BIBLIOGRAPHY
- Journal papers
- Datamonitor reports
APPENDIX
|
